Amit Bahl is Consultant Clinical Oncologist and Head of Radiotherapy at Bristol Haematology & Oncology Centre with a special interest in breast and urological cancers.
He is the research lead for Bristol haematology and Oncology Centre (BHOC). He has led and developed the prostate brachytherapy service at BHOC. He has been an expert adviser to NICE for the technology appraisal on new drugs and an external service reviewer at oncology departments elsewhere in the country.
Prior to his current roles, Dr. Bahl became Member of the Royal College of Physicians (UK) and trained in Clinical Oncology, achieving the Fellowship of the Royal College of Radiologists qualification. He has been awarded the fellowship of the Royal College of Physicians.
He is a current member of the National Cancer Research Institute (NCRI) Clinical Studies Groups for prostate, bladder and penile cancer, college tutor of the Royal College of Radiologists and has also supervised three MD research projects in breast and prostate cancer. He has previously been in the NCRI Renal clinical studies group.
Dr. Bahl is actively involved in research into breast, prostate and bladder cancers, participates in clinical trials locally and nationally and regularly publishes articles in these research areas.